India Coronavirus update: 18 States & UTs record zero deaths
On Friday, March 5, 2021, India recorded 16,838 new cases of Covid-19 taking the tally in-country to 1,11,73,761. The number of active cases now stands at 1,76,319 which is 1.58% of the total number of coronavirus infections. The recovered number of cases stands at 1,08,39,894.
According to the Health Ministry, few states including Punjab, Maharashtra, Gujarat, Delhi, and Madhya Pradesh. Six states have accounted for 84% of new cases – Gujarat, Kerala, Maharashtra, Karnataka, Punjab, and Tamil Nadu.
Furthermore, health ministry stated that 18 States and Union Territories haven’t reported any death in last day. These states and UTs include Arunachal Pradesh, Andaman and Nicobar Islands, Assam, Chandigarh, Dadra and Nagar Haveli, Daman and Diu, Gujarat, Haryana, Himachal Pradesh, Ladakh, Meghalaya, Manipur, Mizoram, Nagaland, Odisha, Puducherry, Sikkim, Tripura and Uttarakhand.
With second phase of vaccination drive in progress from March 1 with people over 60 years and 45+ with co-morbidities, 1,80,05,503 people have been vaccinated so far. Of this, on Thursday 13,88,170 people received their vaccines, which was also the highest till now.
Related Posts
Kerala Chief Minister Pinarayi Vijayan has urged people to take the indigenously developed Covaxin vaccine by Bharat Biotech without any hesitation as the third phase interim results of clinical trials are available now. He said at a press meet on Thursday said, “There was some reluctance among the public to take the vaccine as part of the delay in getting the results of its third phase trials. The Indian Council of Medical Research has now released the interim results of the third phase clinical trials. According to it, the vaccine has shown an interim efficacy of 81% in preventing Covid-19.”
He further added, “As per ICMR, Covaxin also has the ability to neutralize the UK variant strain of SARS-CoV-2. Therefore, based on this evidence, people should be ready to accept Covaxin along with Covishield vaccine.”